Key Points
Citigroup and Morgan Stanley maintained Buy and Overweight ratings on SCRYY with raised price targets.
Citi raised target to EUR 35.70 from EUR 34.30, Morgan Stanley to EUR 37.50 from EUR 36.00.
Meyka AI rates SCRYY B+, reflecting solid fundamentals and 6.1% dividend yield.
Analyst consensus shows 5 Buy ratings with no Sell recommendations, supporting long-term outlook.
Two major investment banks kept their bullish stances on SCOR SE (SCRYY) this week, signaling confidence in the Paris-based reinsurer. Citigroup and Morgan Stanley both maintained their analyst ratings while raising price targets, reflecting optimism about the company’s near-term prospects. SCOR trades at $3.65 with a market cap of $65.4 billion. The analyst ratings maintained by these firms suggest steady momentum in the reinsurance sector. These moves come as the company prepares for earnings in late July.
Analyst Ratings Maintained on SCOR SE
Citigroup Raises Price Target
Citigroup kept its Buy rating on SCRYY while raising the price target to EUR 35.70 from EUR 34.30 on May 7. This price target increase reflects stronger fundamentals in the reinsurance market. The analyst ratings maintained by Citi suggest confidence in SCOR’s operational execution. The EUR 1.40 increase signals positive momentum heading into the second half of 2026.
Morgan Stanley Maintains Overweight
Morgan Stanley also held its Overweight rating while boosting its price target to EUR 37.50 from EUR 36.00 on the same day. This analyst ratings maintained stance underscores Morgan Stanley’s conviction in SCOR’s growth trajectory. The EUR 1.50 increase represents the largest upward revision between the two firms. Both moves occurred when SCRYY traded near $3.74, before declining to current levels.
SCOR’s Financial Position and Meyka Grade
Strong Fundamentals Support Ratings
SCOR operates as a global reinsurer with $65.4 billion in market cap and 17.9 billion shares outstanding. The company generated $0.55 in earnings per share with a PE ratio of 6.64, indicating attractive valuation. Meyka AI rates SCRYY with a grade of B+, reflecting solid financial health. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The B+ rating suggests the stock offers reasonable value relative to peers in the Financial Services sector.
Dividend Yield and Cash Position
SCOR offers a dividend yield of 6.10%, providing income to shareholders. The company maintains strong liquidity with $1.21 in cash per share. Operating margins stand at 26.1%, demonstrating efficient cost management. These metrics support the analyst ratings maintained by both Citi and Morgan Stanley. The reinsurer’s ability to generate consistent cash flow strengthens its competitive position in the insurance sector.
Market Performance and Technical Outlook
Recent Price Action
SCRYY declined 3.18% on May 8, closing at $3.65 after trading between $3.56 and $3.74. The stock trades above its 200-day moving average of $3.40, suggesting intermediate-term strength. Year-to-date performance shows a gain of 7.99%, outpacing broader market weakness. The analyst ratings maintained by major firms provide support during short-term volatility. Volume remains light at 1,112 shares, typical for ADR trading on pink sheets.
Consensus and Forecast
Analyst consensus shows 5 Buy ratings and 1 Hold, with no Sell recommendations. SCRYY carries a consensus rating of 3.0 (Buy). Meyka’s AI price forecasts suggest $3.66 for 2026 and $5.13 by 2031, implying 40% upside over five years. These grades are not guaranteed and we are not financial advisors. The analyst ratings maintained this week reinforce the bullish outlook.
Why Analyst Ratings Remained Steady
Reinsurance Sector Tailwinds
The reinsurance industry benefits from rising premium rates and strong demand for risk transfer. SCOR’s diversified portfolio across property, casualty, and life reinsurance reduces concentration risk. The analyst ratings maintained by Citi and Morgan Stanley reflect confidence in these structural advantages. Both firms see pricing power persisting through 2026. SCOR’s global footprint across Europe, Americas, and Asia-Pacific positions it well for growth.
Earnings Growth and Capital Strength
SCOR reported net income growth of 211.75% year-over-year, driven by improved underwriting results. Operating cash flow grew 16.5%, supporting dividend sustainability. The company’s debt-to-equity ratio of 0.81 remains manageable for the sector. These metrics justify the analyst ratings maintained by major investment banks. Return on equity of 19.8% exceeds many financial services peers, validating management’s capital allocation strategy.
Final Thoughts
Citigroup and Morgan Stanley maintain analyst ratings while raising SCOR SE price targets to EUR 35.70 and EUR 37.50, signaling confidence in the reinsurance business. The company’s strong dividend yield of 6.1%, solid cash generation, and B+ credit grade support a bullish outlook. With analyst consensus at Buy and five-year forecasts showing 40% upside potential, these maintained ratings provide a solid foundation for long-term investors. Earnings on July 30 will offer the next catalyst for stock movement.
FAQs
Both firms raised price targets while maintaining Buy and Overweight ratings, reflecting confidence in SCOR’s reinsurance fundamentals, premium pricing power, and 211.75% year-over-year earnings growth.
Citigroup raised its target to EUR 35.70 from EUR 34.30; Morgan Stanley increased to EUR 37.50 from EUR 36.00. Both represent meaningful upside from SCRYY’s current $3.65 trading level.
Meyka AI rates SCRYY B+, reflecting solid financial health and reasonable valuation based on S&P 500 comparison, sector performance, and analyst consensus. Grades are not guaranteed investment advice.
SCOR offers 6.10% dividend yield, significantly above the S&P 500 average of 1.3%, appealing to dividend-focused investors seeking reinsurance exposure with attractive income returns.
SCOR reports earnings July 30, 2026, providing the next catalyst for analyst ratings to shift based on financial results and management guidance.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)